Calliditas Therapeutics AB (publ)
CALT
NASDAQ
06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -6.31% | -22.57% | -19.20% | 8.92% | -2.84% |
Total Receivables | 54.79% | 61.63% | 140.85% | -28.94% | 162.94% |
Inventory | 131.00% | 133.38% | 480.54% | 2,702.86% | 2,203.93% |
Prepaid Expenses | 15.34% | -12.26% | 52.98% | 112.61% | 59.16% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | 9.98% | -150.00% | 0.00% |
Total Current Assets | 5.52% | -12.74% | -6.41% | 8.49% | 11.32% |
|
|||||
Total Current Assets | 5.52% | -12.74% | -6.41% | 8.49% | 11.32% |
Net Property, Plant & Equipment | 45.61% | 48.80% | 76.13% | 57.75% | 7.63% |
Long-term Investments | -- | -- | 9.99% | -- | -- |
Goodwill | -- | -- | 9.99% | -- | -- |
Total Other Intangibles | -16.23% | -15.30% | 1.92% | 10.05% | 17.34% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 60.91% | 21.61% | 109.37% | 105.02% | 230.28% |
Total Assets | 4.05% | -8.59% | -1.32% | 8.20% | 11.32% |
|
|||||
Total Accounts Payable | 113.38% | -9.08% | -35.02% | -28.53% | -16.22% |
Total Accrued Expenses | 36.86% | 56.75% | 113.18% | 134.03% | 120.08% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | 25.26% | -- | -- |
Total Finance Division Other Current Liabilities | -11.86% | -2.49% | -22.77% | -- | -- |
Total Other Current Liabilities | -11.86% | -2.49% | -22.77% | -- | -- |
Total Current Liabilities | 50.69% | 27.49% | 29.76% | 59.58% | 54.49% |
|
|||||
Total Current Liabilities | 50.69% | 27.49% | 29.76% | 59.58% | 54.49% |
Long-Term Debt | 31.75% | 31.95% | 36.58% | 68.44% | 64.84% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 27.95% | 27.82% | 77.79% | 56.22% | -5.58% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 52.68% | -2.46% | 17.75% | 40.68% | 27.28% |
Total Liabilities | 38.59% | 26.64% | 33.15% | 62.01% | 55.23% |
|
|||||
Common Stock & APIC | 2.40% | -3.13% | 5.74% | -99.90% | -99.91% |
Retained Earnings | -- | -- | -30.14% | -- | -- |
Treasury Stock & Other | -78.83% | -80.57% | -158.26% | -- | -- |
Total Common Equity | -78.45% | -80.26% | -54.71% | -50.53% | -33.56% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -78.45% | -80.26% | -54.71% | -50.53% | -33.56% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -78.45% | -80.26% | -54.71% | -50.53% | -33.56% |
|